Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments
about
sameAs
Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virusHIV-1 expression induces cyclin D1 expression and pRb phosphorylation in infected podocytes: cell-cycle mechanisms contributing to the proliferative phenotype in HIV-associated nephropathy.The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trialsSynaptic Plasticity and Neurological Disorders in Neurotropic Viral InfectionsCocaine potentiates astrocyte toxicity mediated by human immunodeficiency virus (HIV-1) protein gp120Lower cognitive reserve in the aging human immunodeficiency virus-infected brain.Decreased basal ganglia activation in subjects with chronic fatigue syndrome: association with symptoms of fatigue.Young-onset dementiaMechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade.Astrovirus encephalitis in boy with X-linked agammaglobulinemia.Neurocognitive impairment and HIV risk factors: a reciprocal relationship.Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disordersHIV-1gp120 induces neuronal apoptosis through enhancement of 4-aminopyridine-senstive outward K+ currentsLower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorderHIV-1 Nef increases astrocyte sensitivity towards exogenous hydrogen peroxideLongitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis.Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders.Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis.Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins.HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuseChanging patterns in the neuropathogenesis of HIV during the HAART era.Cerebrospinal fluid is an efficient route for establishing brain infection with feline immunodeficiency virus and transfering infectious virus to the periphery.Screening for cognitive impairment in human immunodeficiency virus.Neuro-ophthalmological disorders in HIV infected subjects with neurological manifestations.Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytesDRD2 and DRD4 genes related to cognitive deficits in HIV-infected adults who abuse alcoholNanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics.Molecular targets of opiate drug abuse in neuroAIDS.Whole brain diffusion tensor imaging in HIV-associated cognitive impairmentSignaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages.Serotonin-Related Gene Polymorphisms and Asymptomatic Neurocognitive Impairment in HIV-Infected Alcohol Abusers.Synaptic dysfunction in human immunodeficiency virus type-1-positive subjects: inflammation or impaired neuronal plasticity?Brain-derived neurotrophic factor modulates expression of chemokine receptors in the brainDevelopment of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection.Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic miceNADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat.Modulation of innate immunity by copolymer-1 leads to neuroprotection in murine HIV-1 encephalitis.Declined neural efficiency in cognitively stable human immunodeficiency virus patients.Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.
P2860
Q24794317-F622DF58-60C4-4AE5-9D42-B4D8AD2D1171Q24804652-A03F59DF-BA8D-440A-80B3-52388A4FD789Q28087336-98DB391B-0190-4EE1-899B-C18306B5A929Q28088477-85F278F2-7069-4D54-964F-28364FE732C6Q28475805-DBC2B6AF-2DF6-4093-B08D-F16C06545BB2Q30440212-9E95B9F0-A9F5-4FDC-86D8-C58638A7EB8DQ33654938-0091434E-FD75-4DCA-B76A-E07F5AEFB65DQ33660849-B0517EDC-1E53-4564-B434-4ADF889159B6Q33770575-70F751E3-E2CC-4D45-BF28-E8CE5487231CQ33915180-D93142E3-32D1-478A-8E54-2C09A2724B24Q34005620-E03561C7-2877-4168-A6BB-0F626E31D079Q34016222-55AB254D-B3DA-49BC-B4F7-1FE592A8BE85Q34053420-37C31265-53D8-4AD3-A0D3-E5CD3AC182BCQ34257820-4C43CEB3-DB81-433D-B872-3F649D53C172Q34573902-6149D224-DA13-425A-8751-42DBD86B8D2AQ34590964-4EBA41F3-BD67-498D-8DBA-CC8EE62A6508Q34776120-F36ABE9B-5931-423E-860E-1D34C70308D3Q34776835-4F864846-07D3-4AB6-A3E8-6631E4DB1F02Q34988322-CC132433-BA64-4509-A86C-2226AED45D8CQ35003533-A7D15AEF-94B5-4480-B7E2-6C67B3F42D9BQ35009465-072E0DB9-F79F-484D-AA66-EC41CC9445DEQ35126422-A568D772-5BC1-45D1-9A32-9A2941273656Q35195923-5B45E2CE-F029-4120-81A4-8461566F00AEQ35215678-9CFE307B-62C3-441B-83C8-7E0A91528849Q35592605-B598BBF1-2C46-4178-95D9-4A72C63D0AC1Q35857699-05864981-4512-486D-B39C-6E706FA9A78FQ35997050-F7151CF6-0779-4BCB-8627-4AE886F190FEQ36107193-985FED9E-200B-42D1-A6DA-09A9F06B0878Q36302053-F8BC5AED-9A33-48B9-B757-A71DBF9ADA00Q36511545-CA91A275-745D-48C9-85FE-75293FAA2672Q36644832-161641A7-98B7-482A-AAF8-B113758EA4C4Q36741429-55A59C95-0C62-4643-B8B1-27D7676FD9A9Q36786375-C8C1FB07-FDB4-476F-B2D4-A07F369BEAD3Q37012549-5567EC2B-AE05-49AD-B026-A51065EEE014Q37234713-2AEDEC90-E862-40F9-BD47-7E6CDF4E5108Q37301018-9344CC85-24D1-4C12-9C3B-642FCC6081DAQ37304937-620B8EE8-9BE8-4955-84FD-96146959CF05Q37325159-41F63175-22C1-427F-9029-82F6CC8A5151Q37325321-899A9496-FA53-41C8-9DF1-197F51FB1139Q37351319-3BD3E042-EB8A-4D0C-AA73-53EF7AA8A909
P2860
Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neuropathology and neurodegene ...... ations according to treatments
@ast
Neuropathology and neurodegene ...... ations according to treatments
@en
Neuropathology and neurodegene ...... ations according to treatments
@nl
type
label
Neuropathology and neurodegene ...... ations according to treatments
@ast
Neuropathology and neurodegene ...... ations according to treatments
@en
Neuropathology and neurodegene ...... ations according to treatments
@nl
prefLabel
Neuropathology and neurodegene ...... ations according to treatments
@ast
Neuropathology and neurodegene ...... ations according to treatments
@en
Neuropathology and neurodegene ...... ations according to treatments
@nl
P2093
P921
P3181
P1476
Neuropathology and neurodegene ...... ations according to treatments
@en
P2093
Adle-Biassette H
Chretien F
Lorin de la Grandmaison G
P304
P3181
P407
P577
2001-07-01T00:00:00Z